- Home
- Publications
- Publication Search
- Publication Details
Title
Precision medicine in acute lymphoblastic leukemia
Authors
Keywords
-
Journal
Frontiers of Medicine
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-19
DOI
10.1007/s11684-020-0759-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
- (2020) Shuhong Shen et al. JAMA Oncology
- Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
- (2019) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
- (2019) Zhaohui Gu et al. NATURE GENETICS
- Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia
- (2019) David T Teachey et al. LANCET ONCOLOGY
- BCL-2 is a Therapeutic Target For Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
- (2019) Ernesto Diaz-Flores et al. CANCER RESEARCH
- Fratricide-resistant CD1a-specific CAR T-cells for the treatment of cortical T-cell acute lymphoblastic leukemia
- (2019) Diego Sánchez-Martínez et al. BLOOD
- Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group
- (2019) Jennifer L. McNeer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling
- (2019) Felix Seyfried et al. Cell Death & Disease
- Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia
- (2019) Hind Rafei et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of testicular relapse of B-cell acute lymphoblastic leukemia with CD19-specific chimeric antigen receptor T cells
- (2019) Xiaojuan Chen et al. Clinical Lymphoma Myeloma & Leukemia
- Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16
- (2019) Sima Jeha et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
- (2018) Karen L. Bride et al. BLOOD
- Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group
- (2018) Kathryn G. Roberts et al. BLOOD
- International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
- (2018) Ondrej Hrusak et al. BLOOD
- SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- (2018) Nicholas J. Short et al. Clinical Lymphoma Myeloma & Leukemia
- TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
- (2018) Maoxiang Qian et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622
- (2018) William B. Slayton et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)
- (2018) Martin Schrappe et al. JOURNAL OF CLINICAL ONCOLOGY
- An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
- (2018) Matthew L Cooper et al. LEUKEMIA
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- COG AALL0434: A randomized trial testing nelarabine in newly diagnosed t-cell malignancy.
- (2018) Kimberly P. Dunsmore et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization
- (2018) Stuart S. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
- Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
- (2018) Deepa Bhojwani et al. LEUKEMIA
- The genetic basis and cell of origin of mixed phenotype acute leukaemia
- (2018) Thomas B. Alexander et al. NATURE
- Chemoimmunotherapy with inotuzumab ozogamicin combined with mini‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage
- (2018) Elias Jabbour et al. CANCER
- Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
- (2018) Ching-Hon Pui et al. Nature Reviews Clinical Oncology
- Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
- (2018) Jian-Feng Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial
- (2018) Andrea Biondi et al. Lancet Haematology
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
- (2018) Elias Jabbour et al. Lancet Haematology
- Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
- (2018) Haiying Qin et al. Molecular Therapy-Oncolytics
- Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
- (2017) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
- (2017) N Toft et al. LEUKEMIA
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- (2017) Yu Liu et al. NATURE GENETICS
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- InheritedTP53Mutations and the Li–Fraumeni Syndrome
- (2017) Tanya Guha et al. Cold Spring Harbor Perspectives in Medicine
- Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
- (2016) S. L. Khaw et al. BLOOD
- Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
- (2016) A. Moricke et al. BLOOD
- Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics
- (2016) Sarah K. Tasian et al. BRITISH JOURNAL OF HAEMATOLOGY
- Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
- (2016) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents
- (2016) Kyogo Suzuki et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2016) Arend von Stackelberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy
- (2016) C-H Pui et al. LEUKEMIA
- Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
- (2016) Takahiko Yasuda et al. NATURE GENETICS
- Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
- (2016) Jinghui Zhang et al. NATURE GENETICS
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia
- (2016) Jessica T. Leonard et al. Science Translational Medicine
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
- (2016) Henrik Lilljebjörn et al. Nature Communications
- Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
- (2016) Zhaohui Gu et al. Nature Communications
- Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
- (2016) Judith M. Boer et al. Oncotarget
- Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
- (2016) Yuan-Fang Liu et al. EBioMedicine
- A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies
- (2015) M. Mamonkin et al. BLOOD
- Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
- (2015) Ute Fischer et al. NATURE GENETICS
- MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
- (2015) Juliana M. Benito et al. Cell Reports
- ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
- (2014) S. Peirs et al. BLOOD
- Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial
- (2014) C. Domenech et al. HAEMATOLOGICA
- Triple Intrathecal Therapy Alone With Omission of Cranial Radiation in Children With Acute Lymphoblastic Leukemia
- (2014) Hsi-Che Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Children With BCR-ABL1–Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
- (2014) Kathryn G. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial
- (2014) Ajay Vora et al. LANCET ONCOLOGY
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199
- (2014) T. N. Chonghaile et al. Cancer Discovery
- An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
- (2013) C J Harrison et al. LEUKEMIA
- Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia
- (2013) M Scherr et al. LEUKEMIA
- The genomic landscape of hypodiploid acute lymphoblastic leukemia
- (2013) Linda Holmfeldt et al. NATURE GENETICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
- (2012) Andrea Biondi et al. LANCET ONCOLOGY
- Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03
- (2012) Gabriele Escherich et al. PEDIATRIC BLOOD & CANCER
- Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
- (2009) Ching-Hon Pui et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation